Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023

BUY
$167.14 - $192.77 $818,651 - $944,187
4,898 Added 363.62%
6,245 $1.09 Million
Q2 2023

Aug 10, 2023

BUY
$160.94 - $186.23 $16,415 - $18,995
102 Added 8.19%
1,347 $231,000
Q1 2023

Apr 24, 2023

SELL
$145.48 - $175.02 $35,788 - $43,054
-246 Reduced 16.5%
1,245 $207,000
Q4 2022

Jan 26, 2023

SELL
$131.14 - $157.47 $32,129 - $38,580
-245 Reduced 14.11%
1,491 $0
Q3 2022

Oct 14, 2022

SELL
$148.29 - $182.55 $23,429 - $28,842
-158 Reduced 8.34%
1,736 $257,000
Q2 2022

Jul 22, 2022

SELL
$155.97 - $200.09 $35,093 - $45,020
-225 Reduced 10.62%
1,894 $325,000
Q1 2022

May 06, 2022

SELL
$181.39 - $234.03 $20,315 - $26,211
-112 Reduced 5.02%
2,119 $399,000
Q4 2021

Feb 08, 2022

BUY
$193.69 - $247.03 $432,122 - $551,123
2,231 New
2,231 $544,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Granite Shares Advisors LLC Portfolio

Follow Granite Shares Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Shares Advisors LLC with notifications on news.